SPRB Company Profile and Key Details

Q: Who are the executives of SPRB?

Dr. Libbie Mansell M.B.A., Ph.D.Chief Regulatory & Quality OfficerDr. Ralph William Charlton III, M.D.Chief Medical OfficerMs. P. J. RamtinSenior Vice President of Bus. OperationsDr. Mojtaba Noursalehi Ph.D.Senior Vice President of BiometricsDr. Javier Szwarcberg M.D., M.P.H.Chief Executive Officer & DirectorMr. Samir M. Gharib CPA, CPA, M.B.A.Pres & Chief Financial Officer

NASDAQ : SPRB

Spruce Biosciences

$52.77

0.9+1.74%

At Close 4:00 PM

58.74

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Spruce Biosciences, Inc. (SPRB) stock surged +1.74%, trading at $52.77 on NASDAQ, up from the previous close of $51.87. The stock opened at $52.66, fluctuating between $50.11 and $53.62 in the recent session.

Stock Snapshot

51.87

Prev. Close

72.4M

Market Cap

50.11

Day Low

-1.44

P/E Ratio

-36.6

EPS (TTM)

-0.81

Cash Flow per Share

52.66

Open

1.37M

Number of Shares

53.62

Day High

59.2%

Free Float in %

1.86

Book Value

56.33K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jun 25, 2026	52.00	53.67	50.11	52.77	56.46K
Jun 24, 2026	52.50	52.51	50.39	51.87	30.83K
Jun 23, 2026	53.49	55.10	52.14	52.14	53.26K
Jun 22, 2026	52.05	55.95	52.00	54.70	96.36K
Jun 18, 2026	49.48	52.90	49.48	52.36	171.02K
Jun 17, 2026	47.72	51.60	46.49	48.76	73.42K
Jun 16, 2026	50.92	51.52	47.10	47.10	61.58K
Jun 15, 2026	51.79	52.13	48.61	49.91	71.11K
Jun 12, 2026	49.18	53.25	49.02	51.89	80.93K
Jun 11, 2026	47.01	49.88	46.50	49.11	69.38K
Jun 10, 2026	48.53	50.38	47.13	47.13	34.05K
Jun 09, 2026	50.72	52.18	46.70	49.03	42.61K
Jun 08, 2026	50.69	51.10	48.67	49.32	31.06K
Jun 05, 2026	53.22	53.22	48.64	50.43	33.89K
Jun 04, 2026	50.02	54.32	50.02	53.17	67.45K
Jun 03, 2026	48.09	50.62	48.00	49.05	65.09K
Jun 01, 2026	50.92	53.08	50.00	50.70	31.19K
May 29, 2026	48.92	51.91	47.49	51.27	54.34K
May 28, 2026	50.33	51.51	48.00	49.19	50.13K
May 27, 2026	51.10	52.62	49.52	49.52	29.87K

Contact Details

Daly City, CA 94014

United States

https://www.sprucebiosciences.com 415 655 4168

About Company

Spruce Biosciences, Inc., founded in 2014 and situated in Daly City, California, operates as a biopharmaceutical enterprise. Its primary objective is to advance and bring to market innovative treatments, particularly for uncommon endocrine conditions. A central component of its therapeutic pipeline is tildacerfont, a non-steroidal drug candidate. This compound is currently undergoing Phase 2b clinical assessments in adult patients with congenital adrenal hyperplasia (CAH), with the aim of optimizing disease management and lessening dependence on steroid medications by examining reductions in glucocorticoid levels and their clinical consequences. Tildacerfont is also progressing through Phase 2 trials for pediatric classic CAH, as well as investigating its efficacy in women suffering from polycystic ovary syndrome (PCOS). Additionally, Spruce Biosciences maintains a collaborative licensing agreement with Eli Lilly and Company to jointly explore, formulate, and commercialize various pharmaceutical substances.

Stock Peers

ARGX

36.15+4.24%

argenx SE$888.65 REGN

-3.29-0.53%

Regeneron Pharmaceuticals, Inc.$620.14 UTHR

-6.51-1.18%

United Therapeutics Corporation$543.39 MDGL

4.03+0.79%

Madrigal Pharmaceuticals, Inc.$513.79 VRTX

4.98+1.05%

Vertex Pharmaceuticals Incorporated$480.18 KRYS

12.3+3.54%

Krystal Biotech, Inc.$359.93 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 PRAX

18.92+6.12%

Praxis Precision Medicines, Inc.$327.86 LGND

11.01+3.86%

Ligand Pharmaceuticals Incorporated$295.92 ALNY

-0.89-0.30%

Alnylam Pharmaceuticals, Inc.$293.17

Frequently Asked Questions

What is the current Spruce Biosciences, Inc. (SPRB) stock price?

Spruce Biosciences, Inc. (NASDAQ: SPRB) stock price is $52.77 in the last trading session. During the trading session, SPRB stock reached the peak price of $53.62 while $50.11 was the lowest point it dropped to. The percentage change in SPRB stock occurred in the recent session was 1.74% while the dollar amount for the price change in SPRB stock was $0.90.

SPRB's industry and sector of operation?

The NASDAQ listed SPRB is part of Biotechnology industry that operates in the broader Healthcare sector. Spruce Biosciences, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of SPRB?

Dr. Libbie Mansell M.B.A., Ph.D.
Chief Regulatory & Quality Officer
Dr. Ralph William Charlton III, M.D.
Chief Medical Officer
Ms. P. J. Ramtin
Senior Vice President of Bus. Operations
Dr. Mojtaba Noursalehi Ph.D.
Senior Vice President of Biometrics
Dr. Javier Szwarcberg M.D., M.P.H.
Chief Executive Officer & Director
Mr. Samir M. Gharib CPA, CPA, M.B.A.
Pres & Chief Financial Officer

How SPRB did perform over past 52-week?

SPRB's closing price is 653.86% higher than its 52-week low of $7.00 where as its distance from 52-week high of $838.13 is -93.7%.

How many employees does SPRB have?

Number of SPRB employees currently stands at 20.

Link for SPRB official website?

Official Website of SPRB is: https://www.sprucebiosciences.com

How do I contact SPRB?

SPRB could be contacted at phone 415 655 4168 and can also be accessed through its website. SPRB operates from 2001 Junipero Serra Boulevard, Daly City, CA 94014, United States.

How many shares of SPRB are traded daily?

SPRB stock volume for the day was 56.33K shares. The average number of SPRB shares traded daily for last 3 months was 68.12K.

What is the market cap of SPRB currently?

The market value of SPRB currently stands at $72.40M with its latest stock price at $52.77 and 1.37M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	20
Beta	3.2
Sales or Revenue	$10.09M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	20
Beta	3.2
Sales or Revenue	$10.09M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

SPRB Company Profile and Key Details

Spruce Biosciences

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Earnings & Analyst Outlook

Company Overview

Valuation Metrics

Key Takeaways

Price Forecast & Outlook